**Solarvest BioEnergy** is a **biotechnology** and **clean energy** startup that has made significant strides in developing the first organic Omega-3 through its wholly-owned division, Eversea America Inc. Since its establishment in **2006**, Solarvest has focused on researching and developing an algae patent portfolio to become a world leader in extracting valuable products from its advanced microalgae platform. The company's proprietary technology platform has shown proof of concept for various applications, including clean energy hydrogen, high-value human therapeutic proteins, and Omega-3 fatty acids for the global nutraceutical market through its division, Eversea America Inc. Their latest investment of $1.00M in **Post-IPO Equity** was received on **February 9, 2017** from Drashta Ventures.
No recent news or press coverage available for Solarvest BioEnergy.